122 related articles for article (PubMed ID: 12878053)
1. Absorption, bioavailability, and metabolism of para-nonylphenol in the rat.
Green T; Swain C; Van Miller JP; Joiner RL
Regul Toxicol Pharmacol; 2003 Aug; 38(1):43-51. PubMed ID: 12878053
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and disposition of the novel dopamine agonist Z-7760 in rat after intravenous and oral administration.
Bollard M; Caldwell J; Taylor GW; Strolin-Benedetti M; Semeraro C
Xenobiotica; 2000 Oct; 30(10):983-91. PubMed ID: 11315106
[TBL] [Abstract][Full Text] [Related]
3. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG
Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645
[TBL] [Abstract][Full Text] [Related]
4. 2,4,6-Tribromophenol Disposition and Kinetics in Rodents: Effects of Dose, Route, Sex, and Species.
Knudsen GA; Trexler AW; Richards AC; Hall SM; Hughes MF; Birnbaum LS
Toxicol Sci; 2019 May; 169(1):167-179. PubMed ID: 30768125
[TBL] [Abstract][Full Text] [Related]
5. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in pharmacokinetics and tissue distribution of 4-n-nonylphenol in rats.
Jeong SH; Jang JH; Cho HY; Lee YB
Arch Toxicol; 2019 Nov; 93(11):3121-3139. PubMed ID: 31552477
[TBL] [Abstract][Full Text] [Related]
8. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
Kurebayashi H; Betsui H; Ohno Y
Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
[TBL] [Abstract][Full Text] [Related]
9. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
10. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man.
Walker DK; Ackland MJ; James GC; Muirhead GJ; Rance DJ; Wastall P; Wright PA
Xenobiotica; 1999 Mar; 29(3):297-310. PubMed ID: 10219969
[TBL] [Abstract][Full Text] [Related]
12. Disposition of SK&F L-190144 in rats and monkeys after oral, intravenous or ocular administration.
Tang-Liu DD; Richman JB; Lin P; Selim S
Biopharm Drug Dispos; 1993 May; 14(4):313-24. PubMed ID: 8499582
[TBL] [Abstract][Full Text] [Related]
13. Absorption, distribution, metabolism and excretion of telmesteine, a mucolitic agent, in rat.
Lee J; Son J; Rhee SW; Kim DH
Xenobiotica; 2003 Jul; 33(7):755-65. PubMed ID: 12893524
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
15. The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).
Seaber E; On N; Dixon RM; Gibbens M; Leavens WJ; Liptrot J; Chittick G; Posner J; Rolan PE; Pack RW
Br J Clin Pharmacol; 1997 Jun; 43(6):579-87. PubMed ID: 9205817
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric determination of p-nonylphenol metabolism and disposition following oral administration to Sprague-Dawley rats.
Doerge DR; Twaddle NC; Churchwell MI; Chang HC; Newbold RR; Delclos KB
Reprod Toxicol; 2002; 16(1):45-56. PubMed ID: 11934531
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.
Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG
Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629
[TBL] [Abstract][Full Text] [Related]
18. Absorption, protein binding, pharmacokinetics and excretion of the anti-ischemic and anti-hypertensive arylpiperazine derivative CDRI-93/478 in rats.
Lal J; Gupta RC
Arzneimittelforschung; 2008; 58(2):62-70. PubMed ID: 18412019
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
[TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution, metabolism, and elimination of 8-2 fluorotelomer alcohol in the rat.
Fasano WJ; Carpenter SC; Gannon SA; Snow TA; Stadler JC; Kennedy GL; Buck RC; Korzeniowski SH; Hinderliter PM; Kemper RA
Toxicol Sci; 2006 Jun; 91(2):341-55. PubMed ID: 16543293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
